Level C· Early human research exploring benefitsCase Report / SeriesPubMed

Breast augmentation in Familial Partial Lipodystrophy: a case report.

Hughes JM., Stephen C., Johnson AB., Wilson S.

Case Report / Series on Face & Skin, published in J Plast Reconstr Aesthet Surg (2011) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
J Plast Reconstr Aesthet Surg (2011)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
21306965
DOI
10.1016/j.bjps.2011.01.001

Abstract (original English)

Familial Partial Lipodystrophy (or Dunnigan-Kobberling syndrome) is characterised by the progressive loss of peripheral subcutaneous fat, with or without truncal involvement. The resultant physical changes in appearance may be dramatic, especially in women, and their psychological impact underestimated. There are limited reports regarding the role of reconstructive procedures to address the physical defects imposed by the various lipodystrophy syndromes, and much of the work to date has focused around facial lipoatrophy in patients with HIV-1 protease inhibitor induced disease. We, however, present a single case report pertaining to the role of breast augmentation in patients with truncal lipoatrophy, as in Familial Partial Lipodystrophy.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
FemaleHumansLipodystrophy, Familial PartialMammaplastySkin TransplantationSubcutaneous FatTransplantation, AutologousYoung Adult

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research